The FDA approved Verona Pharma’s drug for chronic obstructive pulmonary disease, or COPD, the first maintenance treatment with a new mechanism for the ailment in …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Rancho Cucamonga, 05/08/2024 / 13:05, PST/PDT – EQS Newswire – Amphastar Pharmaceuticals, Inc. Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) (“Amphastar” or the “Company”) today reported results for
What You Should Know: – The U.S. healthcare system is rapidly embracing AI, and NVIDIA is at the forefront of this transformation, providing powerful tools
Co-locating COVID-19 vaccination and infectious disease testing with a syringe services program boosted engagement among people who injected drugs, according to an analysis of the